ArticleNPJ digital medicine2026
A foundational model encodes deep phenotyping data and enables diverse downstream applications.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep phenotyping data are essential for understanding disease mechanisms and individual health trajectories. However, its unprecedented scale and complexity pose significant analytical challenges that conventional approaches struggle to address. Here, we introduce ukbFound, a foundation model that encoded thousands of individual-level traits into language-like sequences. By incorporating domain-specific tokenization, position-free embedding, and interpretable reasoning, ukbFound effectively captures latent disease-trait relationships from 502,118 UK Biobank individuals. We demonstrate its versatility in three downstream applications. In disease stratification, ukbFound identifies distinct patient subgroups in 289 diseases, with 53/289 (18.3%) showing FDR-significant prognostic differences. Notably, ukbFound reveals two subgroups in chronic obstructive pulmonary disease distinguished by unique basophil count distributions, suggesting a novel indicator for lung function decline. In multimorbidity network analysis, ukbFound uncovers previously unreported associations (e.g., low platelet disorder and gout) and disease communities with shared etiological mechanisms. In disease prediction, ukbFound identified high-risk individuals based solely on lifestyle and dietary data, outperforming ten benchmark models by ΔAUC gains of +0.03 to +0.16. Notably, the highest-risk group showed 17.5-fold greater odds of developing gout up to 8 years in advance. Collectively, ukbFound provides a scalable and interpretable framework for modeling deep phenotyping data and advancing precision medicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.